Generic pharmaceutical company Actavis has launched 29 new products in Bulgaria during the first three months of the year.
The company plans to launch a total of 43 new products in Bulgaria during 2008.
The newly launched products include Fosinopril HCT (cardiovascular) and Lisinopril HCT (cardiovascular), both of which were first to market in Bulgaria.
Actavis also released Sertraline (antidepressant), Bicalutamide (oncology) and Irinotecan (oncology), which has also recently marketed in the US.
Of the 29 products, 23 are nutritional supplements (ActaVit® vitamins; Doctor Mom and ActaStyle dietary supplements) and products from the Decubal cosmetics line.
Actavis is a leading generic pharmaceutical company which specialises in the development, manufacture and sale of generic pharmaceuticals. Based in Iceland, the company has operations in 40 countries and 11,000 employees.
For more information on Actavis in Bulgaria visit www.actavis.bg
Kent, UK – December 30, 2025 — Choice Carpets, a long-established family-run flooring specialist, continues…
India – January 1, 2026 — Sigzen Technologies, a provider of industry-focused ERP solutions, today…
REYKJAVIK, ICELAND – December 12, 2025 – Hertz Iceland is proud to announce it has…
Ontario, Canada — December 11, 2025 — Artsyl Technologies, Inc., a global leader in intelligent…
London, United Kingdom — 12 December 2025 — A new UK-wide platform, AfterShoolClubs.co.uk, has officially…
Galveston, Texas — December 10, 2025 — A Galveston-based bar tour operator has introduced what…
